Skip to search.
 TSX Up 1.96% TSX Ventures Up 0.03%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
33.17 Down 0.31(0.93%) 1:11PM EST - Nasdaq Real Time Price
Prev Close:33.48
Open:33.50
Bid:33.30 x 300
Ask:33.31 x 200
1y Target Est:47.67
Beta:1.57462
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:33.00 - 34.17
52wk Range:25.50 - 43.63
Volume:500,884
Avg Vol (3m):635,040
Market Cap:1.43B
P/E (ttm):637.88
EPS (ttm):0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORDown 0.93%1.43B
BIIBDown 0.33%53.42B

Key Statistics

Forward P/E (1 yr):35.43
P/S (ttm):2.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :1.04
Quarterly EPS Est (Mar-16) :0.01
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback